T. Sutherland

发表

Changes in Management After 18 F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes

L. Wong, K. Yap, S. Koschel, 2022 .

Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL).

L. Wong, L. Tarlinton, Hadia Khanani, 2024, European urology oncology.

Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database

M. Frydenberg, J. Yaxley, J. Calais, 2023, The Journal of Nuclear Medicine.